Wang et al. discovered that ALDOA promotes tumor glucose metabolism and growth, and that HDPS-4II, by specifically inhibiting ALDOA, significantly suppresses glucose metabolism and tumor growth in HCC, highlighting its potential as a novel therapeutic approach for HCC 214. Here, ALDOA is linked to hepatocellular carcinoma.